Edit |   |
---|---|
Antigenic Specificity | CD221, Human (Robatumumab biosimilar) |
Clone | Robatumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD221 Recombinant Antibody (Robatumumab). Robatumumab (proposed INN, also known as SCH 717454 and MK-7454) is a monoclonal antibody and an antineoplastic by Merck and Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor. Phase 2 clinical trials in patients with colorectal cancer, osteosarcoma and Ewing's sarcoma are complete. Merck has since discontinued development. |
Immunogen | n/a |
Other Names | Anti-CD221 Recombinant Antibody, Research Grade Robatumumab, Anti-Human CD221 Recombinant Antibody(Robatumumab), 19D12, SCH 717454, Antibody Drug Analogues, Monoclonal Antibody, YR1196, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 934235-44-6 |
Catalog # | YR1196 |
Price | please inquire |
Order / More Info | CD221, Human (Robatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |